In addition, we discovered that P4HA1 expression was positively linked to tumor mutation burden (TMB) and microsatellite instability (MSI) in several tumor types, demonstrating a potential association with immunotherapy efficacy (Figures 11A,B). The gene discussed is P4HA1; the disease is neoplasm.